Changes the discount rate for structured judgments in medical malpractice actions.
Summary
This bill amends New York’s Civil Practice Law and Rules section 5031, which governs how courts calculate the present value of structured judgments in medical malpractice cases. Under current law, the discount rate for payment streams beyond 20 years is tied to the ten-year U.S. Treasury bond rate plus two percentage points. The bill would replace that approach with a calculation based on the ten-year Treasury rate for the first 20 years and the thirty-year Treasury bond rate for years after 20, averaged on an annual basis.
The measure applies only to structured judgments in medical malpractice actions and would take effect immediately, applying to verdicts entered on or after the effective date. In practical terms, it changes the financial assumptions used to value long-term future payments, which can affect the size and cost of awards in malpractice cases for defendants, insurers, and injured plaintiffs receiving structured settlements.
Impact
The bill would amend CPLR 5031 to alter the statutory discount-rate formula used by courts when converting future periodic payments into present value in medical malpractice structured judgments. By shifting the post-20-year benchmark from the ten-year Treasury rate plus a fixed spread to the thirty-year Treasury rate, the bill would change how long-term awards are calculated and could affect settlement negotiations, verdict valuations, and insurance exposure in malpractice litigation. It does not create a new cause of action or change liability standards, but it would directly affect the economic calculation of damages in covered cases.
Sentiment
Based on the bill text and available context, the measure appears to be a technical but meaningful adjustment to an existing damages-calculation rule, with no recorded committee debate or votes provided. The sponsor’s framing suggests a policy goal of updating the discount-rate methodology to better reflect long-term Treasury benchmarks. Because there is no transcript or voting history, the overall sentiment cannot be measured directly, but the bill reads as a targeted reform rather than a broad or controversial overhaul.
Contention
The main point of contention is likely to be the effect on the value of medical malpractice awards and the corresponding cost to defendants and insurers. Plaintiffs may view the change as a more accurate or favorable way to value long-term structured payments, while defense interests may argue it could increase award amounts or litigation costs. Another possible issue is whether using the thirty-year Treasury rate is a better proxy for long-term discounting than the current formula, especially for payments extending beyond two decades.